Moreover, clinical trials demonstrated that the plasma levels of TNFα, IL-1β, IL-6, and IL-8 were higher in patients with IBS than in controls, while the serum level of IL-10 was significantly lower (Figure 1) [31,32,33]. The gene discussed is IL1B; the disease is irritable bowel syndrome.